DMSO-PDT of BCC - A 6 Year Follow up

Dimethylsulphoxide-supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curettage - A 6 Year Clinical and Histological Evaluation.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00218829

Enrollment

Registered

2005-09-22

Start date

1997-09-30

Completion date

2004-12-31

Last updated

2017-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Basal Cell

Keywords

Photodynamic treatment, Basal cell carcinoma, DMSO

Brief summary

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* histological verified bcc. * one or two PDT treatments with treatment interval no longer than two weeks. * lesion complete response three months after therapy.

Exclusion criteria

* pregnant. * Gorlin's syndrome. * morpheaform or pigmented bcc. * histology older than one year. * tumour infiltration more than four mm. * previous PDT treated lesions.

Outcome results